BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15533657)

  • 1. Dystonia in a 13-year-old boy with secondary progressive multiple sclerosis.
    Shiraishi K; Higuchi Y; Ozawa K
    Brain Dev; 2004 Dec; 26(8):539-41. PubMed ID: 15533657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible parkinsonism and dystonia following probable mycoplasma pneumoniae infection.
    Kim JS; Choi IS; Lee MC
    Mov Disord; 1995 Jul; 10(4):510-2. PubMed ID: 7565836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pathophysiological basis of dystonia].
    Artieda J; García De Casasola MC; Pastor MA; Alegre M; Urriza J
    Rev Neurol; 2001 Mar 16-31; 32(6):549-58. PubMed ID: 11353996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal myoclonus-dystonia of the leg secondary to a lesion of the posterolateral putamen: clinical and neurophysiological features.
    Mahant N; Cordato DJ; Fung VS
    Mov Disord; 2003 Apr; 18(4):452-5. PubMed ID: 12671956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
    Kremenchutzky M; Rice GP; Baskerville J; Wingerchuk DM; Ebers GC
    Brain; 2006 Mar; 129(Pt 3):584-94. PubMed ID: 16401620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
    Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemiplegic ALS: Mills syndrome.
    Rajabally YA; Hbahbih M; Abbott RJ
    Neurology; 2005 Jun; 64(11):1984-5. PubMed ID: 15955966
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism/dystonia syndrome secondary to multiple sclerosis with anti-basal-ganglia antibodies.
    Delgado S; Baez S; Singer C; Sengun C; Sheremata WA; Papapetropoulos S
    Mov Disord; 2009 Jan; 24(2):309-11. PubMed ID: 18951536
    [No Abstract]   [Full Text] [Related]  

  • 11. [Juvenile-onset dystonia with bilateral atrophy of the basal ganglia on MRI].
    Terao Y; Hashimoto K; Chiba A; Inoue K; Mannen T
    Rinsho Shinkeigaku; 1991 Sep; 31(9):1010-4. PubMed ID: 1769149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystonia and multiple sclerosis.
    Anlar B
    Brain Dev; 2005 Dec; 27(8):602; author reply 602. PubMed ID: 16310595
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G; Lavorgna L; Russo P; Prinster A; Dinacci D; Savettieri G; Quattrone A; Livrea P; Messina C; Reggio A; Bresciamorra V; Orefice G; Paciello M; Brunetti A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Patti F; Salemi G; Cammarata E; Simone IL; Salvatore M; Bonavita V; Alfano B
    Neurology; 2005 Jul; 65(2):280-5. PubMed ID: 16043800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression in familial and nonfamilial MS.
    Koch M; Uyttenboogaart M; Heerings M; Heersema D; Mostert J; De Keyser J
    Mult Scler; 2008 Apr; 14(3):300-6. PubMed ID: 18208881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
    Sormani MP; Rovaris M; Comi G; Filippi M
    Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle abnormalities in two patients with dystonia.
    Niiyama T; Higuchi I; Uchida Y; Horikiri T; Arimura K; Osame M
    Acta Neuropathol; 2002 Dec; 104(6):670-3. PubMed ID: 12410389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post-hemiplegic dystonia with a discrete lesion in the postero-lateral part of the contralateral putamen].
    Takahashi K; Mochizuki H; Yoshino H; Imai H; Mizuno Y
    Rinsho Shinkeigaku; 1991 Jun; 31(6):662-5. PubMed ID: 1934784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxysmal dystonia with thalamic lesion in multiple sclerosis.
    Zenzola A; De Mari M; De Blasi R; Carella A; Lamberti P
    Neurol Sci; 2001 Oct; 22(5):391-4. PubMed ID: 11917977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Clin Immunol; 2006 Jan; 118(1):77-82. PubMed ID: 16275091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.